July 27, 2007 - Vascular disease frequently shows no symptoms until it is at such an advanced stage that it is difficult or impossible to treat. Narrowing of the carotid or lower extremity arteries and enlargement of the main artery in the abdomen (abdominal aorta) are some examples of this "silent" disease.

Non-invasive ultrasound testing has been used to quickly and accurately detect these vascular problems, and "screening" events have become popular tools for early diagnosis and to increase public awareness about these problems.

July 27, 2007 – Cardiac Science Corp., a cardiac monitoring and defibrillation products company, received Frost & Sullivan’s award for Global Excellence in ECG Monitoring, which recognizes its leadership and innovative vision in the cardiac monitoring marketplace.

Frost & Sullivan determines the Award recipient based on numerous factors, including the company’s business development, competitive strategy and leadership within the Frost & Sullivan ECG Monitoring Industry Research Group.

July 27, 2007 - Medicomp Inc., a wholly owned subsidiary of United Therapeutics Corporation, recently introduced CardioPAL SAVI, an atrial fibrillation (AF) burden statistical package available on an ambulatory cardiac event monitor designed to assess the severity of a patient’s AF over an extended period.

July 27, 2007 - Medicomp Inc., a wholly owned subsidiary of United Therapeutics Corporation, recently introduced CardioPAL SAVI, an atrial fibrillation (AF) burden statistical package available on an ambulatory cardiac event monitor designed to assess the severity of a patient’s AF over an extended period.

July 26, 2007 - St. Jude Medical Inc. announced that the FDA has granted clearance for the 7F Proxis Embolic Protection System, a system designed to extract debris that may become dislodged when an intervention, such as delivering a stent, is performed on patients who have previously undergone a heart bypass procedure using a saphenous vein graft (SVG).

July 26, 2007 - St. Jude Medical Inc. announced that the U.S. FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation, in addition to receiving a Health Canada License.

July 26, 2007 - CardiacAssist Inc., a Pittsburgh-based medical device company, announced it has completed the 1000th worldwide procedure utilizing the TandemHeart System, which is used in 20 ranked heart and heart surgery hospitals.

July 25, 2007 – Multidetector computed tomography (MDCT) angiography is highly accurate in depicting intracranial aneurysms, according to a study published in the August issue of Radiology. In addition, MDCT angiography can be used to quickly determine the possibility of using minimally invasive treatment rather than open surgery.

July 25, 2007 - Teleflex Incorporated, a diversified company expanding medical technology business, and Arrow International Inc., a provider of catheter-based access and therapeutic products for critical and cardiac care, announced that they have entered into a definitive agreement pursuant to which Teleflex will acquire Arrow in an all cash transaction valued at approximately $2 billion.

July 25, 2007 – Using 64-slice coronary CT angiography as a diagnostic test poses a substantial risk of developing radiation-induced cancer for women and younger patients, according to a study published in the Journal of the American Medical Association earlier this month.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now